Atlas Trials

Clinical Trial on the Safety, Tolerance and Preliminary Efficacy of XH001 Injection Combined With Neoantigen Vaccine-induced Tumor-specific T-cell Injection in Advanced Gastric Cancer

Clinical trial NCT07298200 · RECRUITING

Trial details

NCT number
NCT07298200
Sponsor
Jia Wei
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Gastric Cancer
Start date
2025-12-26
Primary completion
2028-06-01
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.